US Stock MarketDetailed Quotes

60 Degrees Pharmaceuticals (SXTP)

Watchlist
  • 1.365
  • -0.015-1.09%
Trading Jun 12 12:58 ET
3.63MMarket Cap-0.20P/E (TTM)

60 Degrees Pharmaceuticals (SXTP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-71.63%-2.74M
-21.26%-6.85M
-3.31%-1.69M
-25.45%-2.11M
-22.04%-1.45M
-40.07%-1.6M
-24.33%-5.65M
-2,473.06%-1.64M
55.20%-1.68M
-279.03%-1.19M
Net income from continuing operations
-11.34%-2.09M
7.38%-7.37M
29.77%-1.44M
-7.25%-2.32M
58.44%-1.73M
-538.64%-1.88M
-108.60%-7.96M
-0.13%-2.05M
-151.77%-2.16M
-24.84%-4.17M
Operating gains losses
189.46%4.57K
84.03%-266.09K
-2,575.59%-422.53K
-62.79%21.1K
12,656.31%140.45K
99.71%-5.11K
-199.85%-1.67M
-87.13%17.07K
-81.04%56.71K
-99.72%1.1K
Depreciation and amortization
53.99%25.87K
30.01%82.87K
47.78%23.57K
55.74%22.83K
78.76%19.68K
-24.10%16.8K
-36.49%63.75K
-31.98%15.95K
-42.36%14.66K
-55.95%11.01K
Change In working capital
-780.24%-554.26K
-102.85%-5.5K
-87.84%26.61K
39.52%-159.65K
-79.18%46.06K
392.42%81.48K
-52.46%192.72K
-83.27%218.93K
89.57%-263.99K
-75.07%221.24K
-Change in receivables
11,725.95%173.81K
91.04%-22.9K
200.90%164.39K
-1,280.60%-379K
873.35%193.21K
98.24%-1.5K
-37.79%-255.42K
-74.58%-162.93K
-118.93%-27.45K
146.58%19.85K
-Change in inventory
99.39%-2K
-2,090.33%-465.84K
-1,576.65%-136.92K
206.61%27.74K
-379.82%-26.18K
-1,173.25%-330.47K
-89.00%23.41K
-93.92%9.27K
-143.77%-26.02K
-91.40%9.36K
-Change in prepaid assets
-663.99%-742.72K
50.57%-19.49K
-149.49%-29.86K
0.29%-253.54K
42.68%132.22K
112.95%131.69K
92.45%-39.42K
-93.91%60.33K
82.79%-254.27K
273.12%92.67K
-Change in payables and accrued expense
-94.09%16.65K
5.21%502.72K
-90.71%29K
917.66%445.15K
-354.81%-253.19K
1,154.94%281.76K
-54.52%477.81K
14.69%312.25K
104.62%43.74K
-88.80%99.36K
-Change in other current liabilities
----
--0
--0
--0
--0
--0
72.85%-13.65K
--0
--0
--0
Cash from discontinued investing activities
Operating cash flow
-71.63%-2.74M
-21.26%-6.85M
-3.31%-1.69M
-25.45%-2.11M
-22.04%-1.45M
-40.07%-1.6M
-24.33%-5.65M
-2,473.06%-1.64M
55.20%-1.68M
-279.03%-1.19M
Investing cash flow
Cash flow from continuing investing activities
-29.89%1.19M
113.49%254.92K
-65,220.83%-1.37M
98.54%-25.49K
60.41%-51.68K
17,447.85%1.7M
-1,530.12%-1.89M
96.85%-2.1K
-6,158.80%-1.75M
-620.25%-130.56K
Capital expenditure reported
--0
-6.86%-55.53K
-1,552.29%-34.67K
36.47%-13.7K
84.18%-4.36K
-286.23%-2.8K
-29.98%-51.97K
80.51%-2.1K
-56.30%-21.57K
-127.36%-27.57K
Net PPE purchase and sale
-1,020.24%-30K
-34.80%-139.88K
---79.88K
27.40%-10K
47.42%-47.32K
---2.68K
-80.09%-103.77K
--0
-655.51%-13.77K
---90K
Net intangibles purchase and sale
---11.44K
10.66%-22.67K
---20.89K
45.89%-1.79K
--0
--0
-38.78%-25.37K
--0
73.14%-3.3K
-116.45%-12.99K
Net investment purchase and sale
-27.69%1.24M
127.69%473K
---1.24M
--0
--0
--1.71M
---1.71M
--0
---1.71M
--0
Cash from discontinued investing activities
Investing cash flow
-29.89%1.19M
113.49%254.92K
-65,220.83%-1.37M
98.54%-25.49K
60.41%-51.68K
17,447.85%1.7M
-1,530.12%-1.89M
96.85%-2.1K
-6,158.80%-1.75M
-620.25%-130.56K
Financing cash flow
Cash flow from continuing financing activities
98.58%3.37M
-8.73%6.44M
47,034.02%458.61K
-16.85%4.28M
0
-10.84%1.7M
8.94%7.05M
973
-13.75%5.15M
-100.27%-865
Net issuance payments of debt
----
----
----
----
----
----
--0
--0
--0
----
Net common stock issuance
96.72%3.37M
-8.37%6.45M
--458.61K
-16.78%4.28M
--0
-9.76%1.71M
11.72%7.04M
--0
-20.30%5.14M
--0
Proceeds from stock option exercised by employees
--0
-74.42%2.8K
--0
--878
--0
-61.44%1.93K
-99.03%10.96K
--973
--0
--5K
Net other financing activities
----
---18K
--0
--0
--0
-10.99%-18K
----
----
-2,382.38%-96.22K
98.22%-5.86K
Cash from discontinued financing activities
Financing cash flow
98.58%3.37M
-8.73%6.44M
47,034.02%458.61K
-16.85%4.28M
--0
-10.84%1.7M
8.94%7.05M
--973
-13.75%5.15M
-100.27%-865
Net cash flow
Beginning cash position
-9.00%1.51M
-22.55%1.66M
24.69%4.12M
24.76%1.97M
19.24%3.45M
-22.55%1.66M
708.90%2.14M
48.78%3.3M
8,167.45%1.58M
9,551.25%2.89M
Current changes in cash
1.09%1.82M
67.66%-156.42K
-58.86%-2.6M
24.69%2.15M
-13.81%-1.5M
139.30%1.8M
-126.64%-483.63K
-1,158.81%-1.64M
-21.36%1.72M
-12,409.58%-1.32M
Effect of exchange rate changes
160.00%5.94K
1,328.26%7.13K
27.70%-1.44K
-30.82%1.23K
1,021.07%17.24K
-1,101.94%-9.9K
-99.19%499
-103.68%-1.99K
-80.97%1.78K
511.23%1.54K
End cash Position
-3.30%3.34M
-9.00%1.51M
-9.00%1.51M
24.69%4.12M
24.76%1.97M
19.24%3.45M
-22.55%1.66M
-22.55%1.66M
48.78%3.3M
8,167.45%1.58M
Free cash flow
-73.63%-2.78M
-21.24%-7.07M
-11.44%-1.83M
-24.11%-2.13M
-13.88%-1.5M
-39.35%-1.6M
-25.12%-5.83M
-1,159.55%-1.64M
54.51%-1.72M
-297.68%-1.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -71.63%-2.74M-21.26%-6.85M-3.31%-1.69M-25.45%-2.11M-22.04%-1.45M-40.07%-1.6M-24.33%-5.65M-2,473.06%-1.64M55.20%-1.68M-279.03%-1.19M
Net income from continuing operations -11.34%-2.09M7.38%-7.37M29.77%-1.44M-7.25%-2.32M58.44%-1.73M-538.64%-1.88M-108.60%-7.96M-0.13%-2.05M-151.77%-2.16M-24.84%-4.17M
Operating gains losses 189.46%4.57K84.03%-266.09K-2,575.59%-422.53K-62.79%21.1K12,656.31%140.45K99.71%-5.11K-199.85%-1.67M-87.13%17.07K-81.04%56.71K-99.72%1.1K
Depreciation and amortization 53.99%25.87K30.01%82.87K47.78%23.57K55.74%22.83K78.76%19.68K-24.10%16.8K-36.49%63.75K-31.98%15.95K-42.36%14.66K-55.95%11.01K
Change In working capital -780.24%-554.26K-102.85%-5.5K-87.84%26.61K39.52%-159.65K-79.18%46.06K392.42%81.48K-52.46%192.72K-83.27%218.93K89.57%-263.99K-75.07%221.24K
-Change in receivables 11,725.95%173.81K91.04%-22.9K200.90%164.39K-1,280.60%-379K873.35%193.21K98.24%-1.5K-37.79%-255.42K-74.58%-162.93K-118.93%-27.45K146.58%19.85K
-Change in inventory 99.39%-2K-2,090.33%-465.84K-1,576.65%-136.92K206.61%27.74K-379.82%-26.18K-1,173.25%-330.47K-89.00%23.41K-93.92%9.27K-143.77%-26.02K-91.40%9.36K
-Change in prepaid assets -663.99%-742.72K50.57%-19.49K-149.49%-29.86K0.29%-253.54K42.68%132.22K112.95%131.69K92.45%-39.42K-93.91%60.33K82.79%-254.27K273.12%92.67K
-Change in payables and accrued expense -94.09%16.65K5.21%502.72K-90.71%29K917.66%445.15K-354.81%-253.19K1,154.94%281.76K-54.52%477.81K14.69%312.25K104.62%43.74K-88.80%99.36K
-Change in other current liabilities ------0--0--0--0--072.85%-13.65K--0--0--0
Cash from discontinued investing activities
Operating cash flow -71.63%-2.74M-21.26%-6.85M-3.31%-1.69M-25.45%-2.11M-22.04%-1.45M-40.07%-1.6M-24.33%-5.65M-2,473.06%-1.64M55.20%-1.68M-279.03%-1.19M
Investing cash flow
Cash flow from continuing investing activities -29.89%1.19M113.49%254.92K-65,220.83%-1.37M98.54%-25.49K60.41%-51.68K17,447.85%1.7M-1,530.12%-1.89M96.85%-2.1K-6,158.80%-1.75M-620.25%-130.56K
Capital expenditure reported --0-6.86%-55.53K-1,552.29%-34.67K36.47%-13.7K84.18%-4.36K-286.23%-2.8K-29.98%-51.97K80.51%-2.1K-56.30%-21.57K-127.36%-27.57K
Net PPE purchase and sale -1,020.24%-30K-34.80%-139.88K---79.88K27.40%-10K47.42%-47.32K---2.68K-80.09%-103.77K--0-655.51%-13.77K---90K
Net intangibles purchase and sale ---11.44K10.66%-22.67K---20.89K45.89%-1.79K--0--0-38.78%-25.37K--073.14%-3.3K-116.45%-12.99K
Net investment purchase and sale -27.69%1.24M127.69%473K---1.24M--0--0--1.71M---1.71M--0---1.71M--0
Cash from discontinued investing activities
Investing cash flow -29.89%1.19M113.49%254.92K-65,220.83%-1.37M98.54%-25.49K60.41%-51.68K17,447.85%1.7M-1,530.12%-1.89M96.85%-2.1K-6,158.80%-1.75M-620.25%-130.56K
Financing cash flow
Cash flow from continuing financing activities 98.58%3.37M-8.73%6.44M47,034.02%458.61K-16.85%4.28M0-10.84%1.7M8.94%7.05M973-13.75%5.15M-100.27%-865
Net issuance payments of debt --------------------------0--0--0----
Net common stock issuance 96.72%3.37M-8.37%6.45M--458.61K-16.78%4.28M--0-9.76%1.71M11.72%7.04M--0-20.30%5.14M--0
Proceeds from stock option exercised by employees --0-74.42%2.8K--0--878--0-61.44%1.93K-99.03%10.96K--973--0--5K
Net other financing activities -------18K--0--0--0-10.99%-18K---------2,382.38%-96.22K98.22%-5.86K
Cash from discontinued financing activities
Financing cash flow 98.58%3.37M-8.73%6.44M47,034.02%458.61K-16.85%4.28M--0-10.84%1.7M8.94%7.05M--973-13.75%5.15M-100.27%-865
Net cash flow
Beginning cash position -9.00%1.51M-22.55%1.66M24.69%4.12M24.76%1.97M19.24%3.45M-22.55%1.66M708.90%2.14M48.78%3.3M8,167.45%1.58M9,551.25%2.89M
Current changes in cash 1.09%1.82M67.66%-156.42K-58.86%-2.6M24.69%2.15M-13.81%-1.5M139.30%1.8M-126.64%-483.63K-1,158.81%-1.64M-21.36%1.72M-12,409.58%-1.32M
Effect of exchange rate changes 160.00%5.94K1,328.26%7.13K27.70%-1.44K-30.82%1.23K1,021.07%17.24K-1,101.94%-9.9K-99.19%499-103.68%-1.99K-80.97%1.78K511.23%1.54K
End cash Position -3.30%3.34M-9.00%1.51M-9.00%1.51M24.69%4.12M24.76%1.97M19.24%3.45M-22.55%1.66M-22.55%1.66M48.78%3.3M8,167.45%1.58M
Free cash flow -73.63%-2.78M-21.24%-7.07M-11.44%-1.83M-24.11%-2.13M-13.88%-1.5M-39.35%-1.6M-25.12%-5.83M-1,159.55%-1.64M54.51%-1.72M-297.68%-1.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More